|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided from operating activities: | |||||
| Provision for credit losses | |||||
| Deferred income tax expense | |||||
| Depreciation of premises and equipment | |||||
| (Accretion) amortization of investment securities deferred, net | |||||
| (Accretion) amortization of premiums and discounts and deferred loan and lease origination costs, net | |||||
| Amortization of identified intangible assets | |||||
| Amortization of debt issuance costs | |||||
| Amortization (accretion) of acquisition fair value adjustments, net | |||||
| Gain on investment securities, net | |||||
| Gain on sales of loans and leases | |||||
| Loss on sales of OREO | |||||
| Write-down of OREO and other repossessed assets | |||||
| Compensation under recognition and retention plans | |||||
| ESOP shares committed to be released | |||||
| Net change in: | |||||
| Cash surrender value of bank-owned life insurance | |||||
| Equity securities held-for-trading | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided from operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales of investment securities available-for-sale | |||||
| Proceeds from maturities, calls, and principal repayments of investment securities available-for-sale | |||||
| Purchases of investment securities available-for-sale | |||||
| Proceeds from maturities, calls, and principal repayments of investment securities held to maturity | |||||
| Proceeds from redemption/sales of restricted equity securities | |||||
| Purchase of restricted equity securities | |||||
| Proceeds from sales of loans and leases held-for-investment, net | |||||
| Net increase in loans and leases | |||||
| Acquisitions, net of cash and cash equivalents acquired | |||||
| Purchase of premises and equipment, net | |||||
| Proceeds from sales of OREO and other repossessed assets | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities: | |||||
| Increase (decrease) in demand checking, NOW, savings and money market accounts | |||||
| Increase in certificates of deposit and brokered certificates of deposit | |||||
| Proceeds from FHLB advances | |||||
| Repayment of FHLB advances | |||||
| Increase (decrease) in other borrowed funds, net | |||||
| Decrease in mortgagors' escrow accounts, net | |||||
| Repurchases of common stock | |||||
| Payment of dividends on common stock | |||||
| Payment of income taxes for shares withheld in share based activity | |||||
| Net cash provided from financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Interest on deposits, borrowed funds and subordinated debt | |||||
| Income taxes | |||||
| Non-cash investing activities: | |||||
| Transfer from loans to other real estate owned and other repossessed assets | |||||
| Acquisition of PCSB Financial Corporation | |||||
| Fair value of assets acquired, net of cash and cash equivalents acquired | |||||
| Fair value of liabilities assumed | |||||
| Common stock issued | |||||
| Common Stock | |||||
| Total common stock issued | |||||
Loading...